Solid Carcinoma

Oncology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Jerusalem Pharmaceuticals
Jerusalem PharmaceuticalsIsrael - Ramallah
1 program
Study of Blood Immune Cells in Cancer Patients Compared to ControlsN/A1 trial
Active Trials
NCT01312701Unknown100Est. Dec 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Jerusalem PharmaceuticalsStudy of Blood Immune Cells in Cancer Patients Compared to Controls

Clinical Trials (1)

Total enrollment: 100 patients across 1 trials

NCT01312701Jerusalem PharmaceuticalsStudy of Blood Immune Cells in Cancer Patients Compared to Controls

Study of Blood Immune Cells in Cancer Patients Compared to Controls

Start: Mar 2011Est. completion: Dec 2013100 patients
N/AUnknown

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space